Worldwide Community Programmes
In 2006, Novartis committed $755 million in corporate citizenship initiatives around the world, particularly focusing on improved access to medicines in the developing world.
The Novartis Foundation for Sustainable Development
The Novartis Foundation for Sustainable Development is a charitable foundation that works at policy and field level to improve access to healthcare for the world’s poorest people. It is one of many Novartis Foundations worldwide which also include scientific and research foundations, as well as venture capital and social foundations.
Access to Medicine projects
Please see below some examples of our Access to Medicine projects:
-
Donations of medicines to patients affected by leprosy (4 million patients cured since 2000)
- Donations of medicines to patients affected by tuberculosis (donations of medication reaching 500,000 patients)
- Malaria treatment at cost in many parts of Asia, Africa and Latin America
- Patient assistance programmes around the world donating medicines to patients affected by chronic myeloid leukemia who cannot afford the treatment
- Relief to support major humanitarian organisations with emergency medical needs ($14 million committed in 2005)
The Novartis Institute for Tropical Diseases
The Novartis Institute for Tropical Diseases in Singapore is run to discover novel treatments and prevention methods for major tropical diseases, such as tuberculosis and dengue fever, to make them available without profit.
BioCamp
The Novartis Biotechnology Leadership Camp (BioCamp) is a pioneering three-day seminar that brings the biotechnology sector closer to talented young people from universities in the UK and across the world.
About Novartis
Novartis has a rich history and a purposeful future.
Careers at Novartis
Our success depends on the creativity and performance of our associates.
Press Office
Novartis UK operates a dedicated Press Office.